DGX - Quest Diagnostics Incorporated
Quest Diagnostics Incorporated Logo

DGX - Quest Diagnostics Incorporated

https://www.questdiagnostics.com
Buy Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Uptrend
As of 2025-09-10 (Snapshot)

Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

52W High
$185.62
52W Low
$144.09
MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
0.54
Valuation
Fair
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
21.97
Forward P/E (<15 better)
17.36
EV/EBITDA (<8 favorable)
12.85
EV/Revenue (<3 favorable)
2.53
P/S (TTM) (<3 favorable)
1.95
P/B (<3 favorable)
2.84
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
0.40%
Institutions (25–75% balanced)
99.17%
Shares Outstanding
111,823,000
Float
111,237,000
Dividend Yield (2–6% sweet spot)
0.02%
Ex‑Dividend Date
2025-10-03
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
10,522,000,000
Gross Profit (TTM)
3,500,000,000
EPS (TTM)
8.35
Profit Margin (>10% good)
0.09%
Operating Margin (TTM) (higher better)
0.15%
ROE (TTM) (>15% strong)
0.14%
EPS YoY (Quarterly) (>10% good)
0.22
Revenue YoY (Quarterly) (>8% good)
0.15
Momentum
Bearish momentum
Value
1.9768
Previous
1.9659
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025